METHOD DECISION FOR DETERMINING SPECIFIC MICROORGANISMS IN PHARMACEUTICAL PRODUCTS: AN OVERVIEW by CENGİZ, Gökhan & YAPAR, Evren ALGIN
 
 
 
Review Article 
 
METHOD DECISION FOR DETERMINING SPECIFIC MICROORGANISMS IN 
PHARMACEUTICAL PRODUCTS: AN OVERVIEW 
 
ABSTRACT 
In the direction of microbiological quality control analysis in pharmaceutical products, 
determining the microbiological load of the product at the end-use stage is very important for 
human health. Quality control parameters in pharmaceutical products vary according to the 
structure of the type of product and administration route. In this context, according to the 
pharmacopoeias, parenteral products and eye drops are classified as sterile products and the 
other group of pharmaceuticals are classified as non-sterile products. However, non-sterile 
pharmaceuticals also must have a certain microbiological quality. For this reason, the 
pharmaceuticals should have a certain microbiological load and should not contain defined 
microorganisms specified to its type. Since the control of the microbiological quality of the 
products is important for safety, itshould be determined by quality control analysis. In this 
study, standard methods used to detect specific microorganism in pharmaceutical products 
were compared.Application steps in standard methods and identification tests of specific 
microorganisms were examined.In addition, studies that are alternative to standard methods 
were evaluated. 
Keywords:Pharmaceutical products, microbiological quality control, method suitability 
study, pharmacopoeial methods, ISO standards. 
 
INTRODUCTION 
Microbiological quality control analysis in pharmaceutical products is one of the most 
fundamental steps in determining the quality of the pharmaceuticals. The microbiological 
load of the final pharmaceutical productis important in terms of its safety and efficacy. In 
addition to the microbiological controls carried out during the manufacturing stages, ensuring 
the microbiological quality of the finished product is the most fundamental issue in 
determining the quality of boththe manufacturing system and the pharmaceutical product. 
Microbiological quality is one of the main issues of Good Manufacturing Practices and 
quality assurance of pharmaceutical products. Since the efficacy and safety of a product 
depends on its pharmaceutical quality, it is necessary to reach the quality target both in the 
related manufacturing stages and in thefinished product. Control and proving of microbial 
quality depends on the application of defined tests. Testing, which is performed on both raw 
materials and finished products, involves microbial enumeration tests for total aerobic 
microbial counts (TAMC) and total yeast and mold counts (TYMC), in addition to tests for 
the following specified microorganisms. Specific microorganisms; Staphylococcus aureus, 
Pseudomonas aeruginosa, Escherichia coli, Salmonella spp., Candida albicans and bile-
tolerant Gram negative bacteria. Ensuring microbiological quality is very important in the use 
of the product due to its toxic or infectious effect. Low levels of pathogenic microorganisms 
can cause serious effects (1). Many requirements and analysis methods have been defined in 
pharmacopoeias for microbiological analysis of pharmaceutical products. United States 
Pharmacopoeia (USP) and European Pharmacopoeia (EP) can be used to determine the 
microbiological quality of pharmacological products. According to the pharmacopoeia 
requirements, the products should have a certain bioburden and should not contain specific 
microorganisms. The microbiological quality of the products varies according to the type of 
the product(2). In this review, microbiological quality control of pharmaceutical products is 
 
 
 
given in terms of method decision and determination of specific microorganisms, which is 
necessary for a comprehensive microbiological quality evaluation of pharmaceuticals.  
 
MICROBIOLOGICAL QUALITY CONTROL METHODS IN PHARMACOPOIEAS 
Internationally accepted pharmacopoeia methods are used in determining microbiological 
quality control. According to the EP and USP, which specifies the analysis methods and 
requirements of internationally accepted pharmaceutical products, the evaluation of 
microbiological quality in pharmaceutical products varies according to their type and route of 
administration.According to EP and USP, pharmaceuticalsare divided into two groups as 
microbiologically sterile and non-sterile products. Pand ocular products which must be 
sterileare subject to the microbiological quality control tests and requirements that are 
specified in USP 71 and EP 2.6.1 Sterility Test Section. The quality control tests and 
requirements of products that are not necessarily sterile are specified in USP 1111 and EP 
5.1.4 Microbial Quality of Non-Sterile Pharmaceutical Preparations and Substances for 
Pharmaceutical Use. Quality control tests of non-sterile pharmaceutical products are subject 
to USP 1111 and EP 5.1.4. Bioburden is determined according toUSP 61 and EP 
2.6.12Microbiological Examination of Non-sterile Products: Microbial Enumeration Tests 
section; specific microorganisms in pharmaceutical products are determined according to the 
section of USP 62 and EP 2.6.13 Microbiological Examination of Non-sterile Products: 
TestsFor Specified Microorganisms section. Microbiological quality control parameters and 
limits according to the administration route of pharmaceuticals are shown in Table 1 (2,3). 
 
Table 1. Microbiological quality control parameters and limits for non-sterile pharmaceutical 
(2,3). 
Route of 
Administration 
TAMC 
(cfu/g or 
cfu/ml) 
TMYC 
 (cfu/g or 
cfu/ml) 
Specified Microorganism(s) 
Nonaqueous 
preparations for oral 
administarion 
103 102 Absence of Escherichia coli (1 g or 1 ml) 
Aqueous preparations 
for oral administarion 
102 101 Absence of Escherichia coli (1 g or 1 ml) 
Rectal administarion 103 102 - 
Oromucosaladminista
rion 
102 101 
Absence of Staphylococcus aureus (1 g or 1 ml) 
Absence of Pseudomonas aeruginosa (1 g or 1 ml) 
Gingival 
administarion 
102 101 
Absence of Staphylococcus aureus (1 g or 1 ml) 
Absence of Pseudomonas aeruginosa (1 g or 1 ml) 
Cutaneous 
administarion 
102 101 
Absence of Staphylococcus aureus (1 g or 1 ml) 
Absence of Pseudomonas aeruginosa (1 g or 1 ml) 
Nasal administarion 102 101 
Absence of Staphylococcus aureus (1 g or 1 ml) 
Absence of Pseudomonas aeruginosa (1 g or 1 ml) 
 
Auricular 
administarion 
102 101 
Absence of Staphylococcus aureus (1 g or 1 ml) 
Absence of Pseudomonas aeruginosa (1 g or 1 ml) 
Vaginal administarion 102 101 
Absence of Staphylococcus aureus (1 g or 1 ml) 
Absence of Pseudomonas aeruginosa (1 g or 1 ml) 
Absence of Candida albicans(1 g or 1 ml) 
Transdermal 
administarion 
(Trandermalpatches) 
 
102 101 
Absence of Staphylococcus aureus (1 g or 1 ml) 
Absence of Pseudomonas aeruginosa (1 g or 1 ml) 
Inhaler administarion 102 101 
Absence of Staphylococcus aureus (1 g or 1 ml) 
Absence of Pseudomonas aeruginosa (1 g or 1 ml) 
Absence of bile-tolerant Gram-negative bacteria (1 g 
or 1 ml) 
 
 
 
 
Microbiological bioburden and specific microorganisms that should not be present in the 
product vary according to the method of use and target. Microbiological bioburden is 
determined quantitatively by determining TAMC and TMYC. In addition to the 
microbiological bioburden, the product should not contain specific microorganisms according 
to the method and target of the pharmaceutical product. Specific microorganism detection is a 
qualitative test. While determining the microbiological quality of the pharmaceutical product, 
the parameters specified in Table 1 should be analyzed and should be within the specified 
limits. While determining the microbiological quality of the product, both the microbiological 
and the specific microorganism quality in grams or ml of the pharmaceutical preparation are 
evaluated (2,3). 
 
SPECIFIC MICROORGANISM DETECTION IN PHARMACEUTICALS 
Specific microorganisms are investigated in order to determine the microbiological quality of 
pharmaceutical products. Recovery of media used for specific microorganism detection is 
very low. For this reason, the pre-enrichment process facilitates the detection of the sought 
microorganism to examine the specific microorganisms. In internationally used methods, pre-
enrichment is routinely applied. Pre-enrichment is the process that increasing the level of the 
specific microorganism. However, in addition to the microorganism sought in this process, 
unwanted microorganisms are also enriched. This may cause a false positive result. 
Bioburden, whose level is increased by the pre-enrichment process, is reduced to the sought 
microorganism by selective enrichment and selective subculture.Pharmacopoeia methods are 
generally used in the analysis of pharmaceutical products.However, the International 
Organization for Standardization (ISO) methods can also be used because the specific 
microorganisms to be analyzed are similar in cosmetic products (4,5). 
 
Specific microorganisms are generally detected in four steps; 
- Non-selective pre-enrichment 
- Selective pre-enrichment 
- Selective subculture 
- Identification 
 
The pharmaceutical product is included in the analysis of specific microorganism detection, 
according to the groups specified in Table 1. The requirements specified in internationally 
applied standards meet these working steps. The media and analysis steps used during the 
studies are similar to the pharmacopoeia methods. 
 
Dissolve process is applied to prepare the pharmaceutical flour for the analysis steps. 
Generally, Buffered Sodium Chloride Peptone Solution pH 7.0, Phosphate Buffer Solution 
pH 7.2, or Soybean–Casein Digest Broth is used in the dissolve process. If necessary, adjust 
topH of 6 to 8.In the dissolve process, 10 g or ml of product is transferred in 90 ml of solvent.  
As a result of this process, the product is dissolved, the pH is balanced and the antimicrobial 
effect is neutralized. A surface-active agent such as 1 g per L of polysorbate 80 may be added 
to assist in the suspension of poorly wettable substances. For fatty products, the dissolution 
process is accelerated with polysorbate 80 added to the solvent. Also, after the sample is 
added to the solvent, if necessary, not more than 40°C or, in exceptional cases, not more than 
45°C.It mixes carefully and if necessary, maintain the temperature in a water bath. When a 
homogeneous solution is obtained, non-selective enrichment can be started. 10 ml sample 
taken from the obtained solution is used in a non-selective pre-enrichment process (4-7). 
 
 
 
 
Non-selective Pre-enrichment 
The non-selective pre-enrichment process is applied to enrich the specific microorganism 
sought in the analyzed pharmaceutical product. Pre-enrichment is usually done in a medium 
that can produce all microorganisms. 
 
In general, Tryptic Soy Broth (TSB) medium is used for pre-enrichment. Since this medium 
is a general productive medium, it can produce all microorganisms. In case of an 
antimicrobial active substance in the content of the analyzed product, the additional 
chemicals can be added to the medium. 1 g or ml of product analyzed in the pre-enrichment 
process is incubated in TSB medium at 30-35°C for 18-24 hours. As a result of incubation, 
microorganisms in 1 gram of product will develop and be easier to detect. In the detection of 
bile-tolerant Gram-negative bacteria indicated in the Table 1, 1 gram or ml of the analyzed 
product is transferred to TSB medium and incubated at 20-25°C for 2-5 hours. In the 
detection of Candida albicans indicated in Table 1, 1 gram or ml of the analyzed product is 
transferred to Sabouraud Dextrose Broth (SDB) medium and incubated at 30-35°C for 3-5 
days. TSB media can be used as an alternative for Candida albicans detection (4-7). 
 
 
Selective Pre-enrichment 
Selective pre-enrichment process is the reduction of the microorganism obtained in the non-
selective pre-enrichment process. This process is not applied in all microorganism groups as 
specified in standard methods. It is applied in searching forEscherichia coli and bile-tolerant 
Gram-negative bacteria from specific microorganisms specified in Table 1. For Escherichia 
coli, 1 ml sample taken from the TSB obtained in the non-selective pre-enrichment process is 
transferred to the MacConkey Broth (MCB) medium. For bile-tolerant Gram-negative 
bacteria, 1 ml sample taken from the TSB obtained in the non-selective pre-enrichment 
process is transferred to the Enterobacter Enrichment Broth (EEB) medium. MCB medium is 
incubated at 42-44°C for 24-48 hours, EEB medium at 30-35°C for 24-48 hours. Selective 
subculture for other specific microorganisms is sufficient to detect the microorganism sought. 
For this reason, there is no need for selective pre-enrichment (4-7). 
 
Selective Subculture 
Selective subculture is transferring only the sought microorganism to a medium where it can 
grow. With this process, only the sought microorganisms are produced and detected. In the 
selective subculture process, MacConkey Agar (MCA) medium is used for Escherichia coli 
detection and the MCA medium is incubated at 30-35°C for 18-72 hours; Mannitol Salt Agar 
(MSA) medium is used for Staphylococcus aureus detection and the MSA medium is 
incubated at 30-35°C for 18-72 hours; Cetrimide Agar (CA) medium is used for 
Pseudomonas aeruginosa detection and the CA medium is incubated at 30-35°C for 18-72 
hours; SabouraudDextorose Agar (SDA) medium is used for Candida albicans detection and 
the SDA medium is incubated at 30-35°C for 24-48 hours; Violet Red Bile Glucose Agar 
(VRBGA) medium is used for bile-tolerant Gram-negative bacteria detection and the 
VRBGA medium is incubated at 30-35°C for 18-24 hours. Colonies with typical signs of 
growth on the plates after incubation are taken for an identification test (4-7). 
 
The above analysis steps have been evaluated in terms of international standards. The 
comparison is given in Table 2 (4-11). 
 
 
 
 
 
 
 
 
Table 2. Specific microorganism detection assessment according to standards (4-11). 
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Non-selective  
pre-enrichment 
Selective 
pre-enrichment 
Selective  
subculture 
EP 
2.6.13 
USP 
62 
ISO 
21150 
ISO 
22718 
ISO 
22717 
ISO 
18416 
EP 
2.6.13 
USP 62 
ISO 
21150, 
ISO 
22718, 
ISO 
22717, 
ISO 
18416 
EP 
2.6.13 
USP 62 
ISO 
21150, 
ISO 
22718, 
ISO 
22717, 
ISO 
18416 
Escherichia coli 
TSB 
30-35°C 
for 18-
24 hours 
TSB 
30-
35°C 
for 
18-24 
hours 
Eugon LT 
100 
Broth1 
30-35°C 
for 18-72 
hours 
MCB 
MCB 
42-44°C 
for 24-
48 hours 
N/A 
MCA 
30-35°C 
for 18-72 
hours 
MCA 
30-35°C 
for 18-72 
hours 
MCA 
30-35°C 
for 18-24 
hours 
Staphylococcus 
aureus 
TSB 
30-35°C 
for 18-
24 hours 
TSB 
30-
35°C 
for 
18-24 
hours 
Eugon LT 
100 
Broth2 
30-35°C 
for 18-72 
hours 
N/A N/A N/A 
MSA 
30-35°C 
for 18-72 
hours 
MSA 
30-35°C 
for 18-72 
hours 
Baird 
Parker 
Agar3 
30-35°C 
for 18-24 
hours 
Pseudomonas 
aeruginosa 
TSB 
30-35°C 
for 18-
24 hours 
TSB 
30-
35°C 
for 
18-24 
hours 
Eugon LT 
100 
Broth4 
30-35°C 
for 18-72 
hours 
N/A N/A N/A 
CA 
30-35°C 
for 18-72 
hours 
CA 
30-35°C 
for 18-72 
hours 
Pseudomo
nas Agar 
P5 
30-35°C 
for 18-24 
hours 
 
Candida albicans 
SDB 
30-35°C 
for 3-5 
days 
SDB 
30-
35°C 
for 3-
5 days 
Eugon LT 
100 
Broth6 
30-35°C 
for 18-72 
hours 
N/A N/A N/A 
SDA 
30-35°C 
for 24-48 
hours 
SDA 
30-35°C 
for 24-48 
hours 
SDA 
30-35°C 
for 18-24 
hours 
Bile-tolerant 
Gram-negative 
bacteria 
TSB 
20-25°C 
for 2-5 
hours 
TSB 
20-
25°C 
for 2-
5 
hours 
Out of 
scope 
EEB 
MCB 
30-35°C 
for 24-
48 hours 
N/A 
VRBGA 
30-35°C 
for 18-24 
hours 
VRBGA 
30-35°C 
for 18-24 
hours 
Out of 
scope 
1
 Alternatively, a medium can be used Soybean Casein Lecithin Poysorbate 80 medium.  
2
 Alternatively, a medium can be used TSB medium. 
3
Alternatively, a medium can be used MSA medium. 
4
Alternatively, a medium can be used Soybean Casein Lecithin Poysorbate 80 medium. 
5
Alternatively, a medium can be used CA medium. 
6
Alternatively, a medium can be used TSB medium. 
Identification 
Identification tests are the process of verifying the positive result obtained.In this process, the 
colonies detected as positive on the medium are identified biologically, morphologically or 
biochemically. Identification tests are determination of colony morphology, determination of 
cellular morphology, Gram staining or other differential staining techniques, basic 
biochemical reactions. The positive results obtained in the selective subculture process 
according to international standards are given in Table 3 (8-12). 
 
 
 
 
 
Table 3.According to international standards, results considered positive in the selective 
subculture procedure (8-12). 
Specific 
Microorganism 
EP 
2.6.13 
USP 62 
ISO 21150 
ISO 22718 
ISO 22717 
ISO 18416 
Escherichia coli 
Growth of colonies 
indicates the possible 
presence of E. coli. This 
is confirmed by 
identification tests. 
Growth of colonies 
indicates the possible 
presence of E. coli. This 
is confirmed by 
identification tests. 
Brick-red; may have 
surrounding zone of 
precipitated bile 
Staphylococcus aureus 
The possible presence of 
S. aureus is indicated by 
the growth of yellow or 
white colonies 
surrounded by a yellow 
zone. This is confirmed 
by identification tests. 
The possible presence of 
S. aureus is indicated by 
the growth of yellow or 
white colonies 
surrounded by a yellow 
zone. This is confirmed 
by identification tests. 
Black, shiny colonies, 
surrounded by clear 
zones (2 mm to 5 mm) 
Pseudomonas 
aeruginosa 
Growth of colonies 
indicates the possible 
presence of P. 
aeruginosa. This is 
confirmed by 
identification tests. 
Growth of colonies 
indicates the possible 
presence of P. 
aeruginosa. This is 
confirmed by 
identification tests. 
Yellow-green pigment 
(pyocyanin), which 
fluoresces under UV 
light. 
Candida albicans 
Growth of white 
colonies may indicate 
the presence of C. 
albicans. This is 
confirmed by 
identification tests. 
Growth of white 
colonies may indicate 
the presence of C. 
albicans. This is 
confirmed by 
identification tests. 
White to beige, creamy 
and convex 
bile-tolerant Gram-
negative bacteria 
All detected colonies are 
considered positive. 
All detected colonies are 
considered positive. 
Out of scope 
 
 
For the identification test, positive results specified in the standards must be observed. 
Identification test should be applied to detect Escherichia coli, Staphylococcus aureus, 
Candida albicans and Pseudomonas aeruginosa according to EP and USP. However, the 
details of the identification tests are not specified.For other specific microorganisms, the 
presence of colonies during the sub-culturing process is sufficient for detection and typical 
colonies that should be seen on the media as a result of sub-culturing were not specified. In 
addition, identification tests in USP are defined by USP 1113 Microbial Characterization, 
Identification and Strain Typing. However, the test and positive results to be performed were 
not specified. For this reason, general standards can be used for identification tests. In the 
ISO standards, which include cosmetic products, typical colony characteristics seen with the 
subculture process are defined. Identification procedures to be appliedto typical colonies are 
defined (12). 
 
According to USP 1113, the first step of identification is to obtain a pure culture. In this 
process, it is carried outby a streaking method on solid media where specific microorganisms 
can grow. This process ensures that sufficient cultureis formed in the subsequent 
identification process. Test details are given in Table 4 (12). 
 
Table 4. Identification tests according to USP 1113 (12). 
Categories Characteristics 
 
 
 
Culture Colony morphology, colony color, shape and size, pigment production 
Morphological 
Cellular morphology, cell size, cell shape, flagella type, reserve material, 
Gram reaction, spore and acid-fast staining, mode of sporulation 
Physiological 
Oxygen tolerance, pH range, temperature optimum and range, salinity 
tolerance 
Biochemical Carbon utilization, carbohydrate oxidation or fermentation, enzyme patterns 
Inhibition Bile salt-tolerance, antibiotic susceptibility, dye tolerance 
Serological Agglutination, fluorescent antibody 
Chemo-taxonomic Fatty acid profile, microbial toxins, whole cell composition 
Ecological Origin of the organism 
 
Identification tests according to USP 1113 
Gram Staining: Gram staining methods include the four-step method: crystal violet (primary 
stain), iodine (mordant), alcohol or alcohol–acetone (decolorizer), and safranin 
(counterstain). In the three-step method, the decolorization and the counterstaining steps are 
combined. Under optimal conditions, Gram-positive organisms retain the crystal violet stain 
and appear blue violet. Gram-negative organisms lose the crystal violet stain, so they contain 
only the counterstain safranin and appear red (12). 
 
Spore Staining: Can be carried out using a malachite green stain for spores  
 
Biochemical Screening: Basically, oxidase test, catalase test and coagulase test can be used in 
biochemical identification tests.Gram negative rods into non-fermenters bacteria oxidase 
positive; enteric bacteria are oxidase negative. Staphylococci and Streptococci are 
separatedfrom the calatase test. Staphylococci catalase negative, Streptococci catalase 
positive. Coagulase testing can be used to separate Staphylococci as coagulase negative and 
coagulase positive Staphylococci (12). 
 
Identification tests according to ISO standards 
Identification tests for determination of below given specific microorganisms are briefly 
explained according to ISO standards. 
 
Identification ofEscerichia coli; Gram staining Gram-negative rods, metallic sheen under 
reflected light and a blue-black appearance under transmitted light colonies should be seen by 
subculture on Eosin-Methylene Blue Agar Medium (EMB) medium (30-35°C for 24-48 h) 
(8).  
 
Identification ofStaphylococcus aureus; Gram staining Gram-positive cocci, catalase positive 
test, coagulase positive test (9). 
 
Identification ofPseudomonas aeruginosa; Gram staining Gram-negative rods, oxidase 
positive test. Inoculate the surface of the Pseudomonas agar medium for the detection of 
pyocyanin with suspectisolated colonies grown on cetrimide agar medium, so that individual 
colonies develop. Incubate at 30-35°C. Check for bacterial growth after 24 h, 48 h and 72 h. 
Pseudomonas aeruginosa forms colonies surrounded by a blue to green zone due to 
pyocyanin formation or with a red to dark brown zone due to pyorubin production (10). 
 
Identification ofCandida albicans; Gram staining, the microscopic observation shall reveal a 
violet colour, short ovoid or elongated cells, sometimes with budding cells. Germ tube 
production; the formation of germ tubes characterizes the presence of Candida albicans (11). 
 
 
 
 
Method Suitability and Growth Promotion Tests 
In the method suitability study, it is aimed to detect the target microorganism group. It must 
be proven that other microorganisms are inhibited. In addition, it should be proven that the 
analyzed pharmaceutical product has no negative effect on the detection of specific 
microorganisms. Target and inhibitory microorganisms used in suitability studies should be a 
reference microorganism. In method, suitability studies, non-selective pre-enrichment process 
should be performed by inoculating the target and inhibited microorganism specified in Table 
5 to the sample prepared by dissolving process. As a result of the procedures performed, the 
tests in which the target microorganisms were inoculated should be positive, and the tests in 
which the inhibited microorganisms were inoculated should be negative. Microorganism 
inoculation amounts in all test groups should be 10-100 colony forming units (cfu) (4-7). 
 
Table 5. Method suitability test target and inhibitory microorganisms (4-7). 
Spesific 
Microorganisms 
Target Microorganism Inhibitory Microorganism 
Escherichia coli Escherichia coli ATCC 8739 Staphylococcus aureus ATCC 6538 
Staphylococcus aureus Staphylococcus aureus ATCC 6538 Escherichia coli ATCC 8739 
Pseudomonas aeruginosa Pseudomonas aeruginosa ATCC 9027 Escherichia coli ATCC 8739 
Candida albicans Candida albicans ATCC 10231 - 
bile-tolerant Gram-
negative bacteria 
Escherichia coli ATCC 8739 
Pseudomonas aeruginosa ATCC 9027 
Staphylococcus aureus ATCC 6538 
 
In the growth promotion test, all the media used in the analysis should be analyzed with the 
microorganisms specified in Table 5. In the growth promotion test, target microorganisms 
should be visible signs of growth as a result of incubation, and inhibitory microorganisms 
should not be a growth sign. The TSB medium used in the non-selective pre-enrichment 
process should be analyzed with 5 different microorganisms in the growth promotion test. 
Since the medium used is the general producer medium, it must be controlled with 5 different 
microorganisms. Control microorganisms for TSB are,Staphylococcus aureus ATCC 6538, 
Pseudomonas aeruginosa ATCC 9027, Bacillus subtilis ATCC 6633, Candida albicans 
ATCC 10231 and Aspergillus brasiliensis ATCC 16404. Microorganism inoculation amounts 
in all test groups should be 10-100 cfu. Incubation temperatures and times in method 
suitability and growth promotion tests are shown in Table 2 (4-7). 
 
Alternative Identification Test Methods for Dedection of Specific Microorganisms 
Alternative methods can be used besides traditional methods for the detection of specific 
microorganisms in pharmaceutical products. All analysis steps are similar for the detection of 
specific microorganisms. However, fast alternative methods can be used for the identification 
test. All analysis steps should be applied prior to the identification test. These alternative 
methods can only be applied at the identification test step. Because pure culture is required 
for the identification step. Traditional methods specified in standard methods or alternative 
methods can be used for the identification of pure culture. Microorganisms in pure culture 
obtained by alternative methods can be detected by biochemical, fatty acid methyl ester 
 
 
 
analysis, MALDI-TOF mass-spectrometry, Fourier transform–Infrared (FT-IR) spectroscopy, 
nucleic acid extraction, PCR amplification and rRNA base sequencing and ribotyping 
methods. Many test kits or identification analysis systems have been developed for these 
methods. Traditional methods used for diagnosis may vary in the phenotypic properties of 
microorganism. Identification tests performed with phenetopic methods may cause false 
results due to the influence of microorgnaism from environmental conditions. For this reason, 
alternative identification methods can be used. Generally, phenotypic methods require more 
pure microorganism cultures than other methods. In addition, the microorganism phenotype 
may change due to the medium used in the detection of specific microorganisms, incubation 
conditions, and the antimicrobial substances in the medium. For this reason, it is necessary to 
use alternative methods to phenotypic analysis methods(13). Alternative identification test 
methods are presented in Table 6. All the alternative identification test methods should be 
confirmed by validation procedures.  
Alternative microbiological methods employ direct and indirect methods of detection; in 
some instances, amplification of the signal is achieved by enrichment methods. In recognition 
of these differences, and for convenience within this chapter, alternative methods for the 
control of microbiological quality are divided into 3 categories: 
 Growth-based methods, where a detectable signal is usually achieved by a period of 
culture. 
 Direct measurement, where individual cells are differentiated and/or imaged; 
 Cell component analysis, where the expression of specific cell components offers an 
indirect measure of microbial presence and identification of micro-organisms (15). 
 
 
Alternative microbiological methods are listed below (15): 
A. Growth-Based Methods 
1.  General critical aspects of methods based on early detection of growth 
2. Electrochemical methods 
3. Measurement of consumption or production of gas 
4. Bioluminescence 
5. Turbidimetry 
6. Growth detection using selective and/or indicative media 
 
B. Direct Measurement 
1. Solid phase cytometry 
2. Flow cytometry 
3. Direct epifluorescent filtration technique (DEFT) 
4. Autofluorescence 
 
C. Cell Component Analysis 
1. Phenotypic techniques 
1.1. Immunological methods 
1.2. Fatty acid profiles 
1.3. Fourier transform infrared (FTIR) spectroscopy 
1.4. Mass spectrometry 
 
 
 
1.5. Biochemical assays based on physiological reactions 
2. Genotypic techniques 
2-1. Direct hybridisation 
2-2. Nucleic acid amplification techniques (NAT) 
2-3. Genetic fingerprinting 
 
Table 6. Alternative identification test systems (13-14). 
Alternative Identification Method System 
Biochemical 
API and ID32  
BBL Crystal 
BiologMicrobial ID System 
Vitek 2 Compact  
BD Phoenix 
Fattyacidmethyl ester analysis MIDI Sherlock 
MALDI-TOF mass-spectrometry 
MALDI-Biotyper 
Vitek MS  
Fouriertransform–infrared (FT-IR) spectroscopy IFS-28B FT-IR spectrometer 
Nucleicacidextraction, PolymeraseChainReaction 
(PCR)amplificationandrRNAbasesequencing MicroSeqIdentificationSystem 
Ribotyping RiboPrinterSystem 
 
Validation of Alternative Microbiological Methods 
Microbiological methods to be used as an alternative need to be validated in order to be 
applied in quality control analysis.Specific microorganism detection is a qualitative test. For 
this reason, the accuracy of the studies should be confirmed with certain analyzes in the 
validation study.This is also the case for identification tests. Alternative fast test systems are 
frequently used. For this reason, the validation of the systems has gained importance. The 
validation criteria of alternative methods for the detection of specific microorganisms are 
shown in Table 7 (15). 
Table 7. Validation of alternative qualitative tests for the presence or absence of 
microorganisms(15). 
Criterion Qualitative test Identification test 
Accuracy + + 
Precision - - 
Specificity + + 
Detection limit + - 
Quantitation limit - - 
Linearity - - 
Range - - 
Robustness + + 
Suitability testing + - 
Equivalence testing + - 
 
 
 
 
 
Critical validation stages are briefly explained below. 
Specificity: In an alternative qualitative test, specificity is the ability to detect only desired 
microorganisms, i.e., the test will not give a false positive result. This can be done using a 
suitable microorganism table. 
Detection Limit: The detection limit of an alternative qualitative method is equal to the lowest 
number of microorganisms that can be detected in a sample under specified analytical 
conditions. The microbiological limit test determines the presence or absence of 
microorganisms in a defined amount of the sample tested. 
Robustness: The robustness of an alternative method is a measure of its capacity to remain 
unaffected by small but intentional changes in method parameters (e.g. incubation time or 
incubation temperature range). 
Suitability testing:The alternative method should be applied in accordance with the specified 
application and with the samples to be analyzed under the responsibility of the users. It 
should show that the test sample does not interfere with the detection capability of the system 
or microbial recovery. 
Equivalence testing: The equivalence testing of two qualitative methods can be done directly 
through the validation parameters. With this approach, testing microorganisms must be 
performed in sufficient replicates with low levels of inoculation (eg, less than 5cfu). 
 
CONCLUSION 
In microbiological quality control analysis of pharmaceutical products, specific 
microorganism detection is very important.Detailed methods for the detection of specific 
microorganisms are described in the pharmacopoeias.In pharmacopoeia methods, the 
preparation of the product, media and incubation conditions are described in detail.In 
pharmaceutical products, neutralization methods of cosmetic products can be used to 
eliminate the antimicrobial effect.When standard methods are compared, they are mostly 
similar. However, the media used vary. 
Indentification tests of microorganisms are specified in ISO standards. However, there is no 
definition for indentification tests in pharmacopoeia methods.It is seen that general 
identification tests are specified only in USP.Especially in identification tests, there are 
deficiencies about how to determine positive results and there are deficiencies about how to 
determine positive results.Nowadays, alternative rapid identification tests have been 
developedfor idnentification tests. However, validation is a must in order to use these systems 
in quality control analysis.Validation of alternative rapid test systems complicates the 
process. However, it shortens the analysis time.Alternative rapid test systems provide 
convenience in the identification phase, but these systems may also require the desired 
microorganism culture.For this reason, alternative rapid test systems also require traditional 
microbiological methods. 
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